PRVA Form 144: Holder Sells Shares; Vesting Entries Listed

PRVA reported Form 144 sales by an affiliated holder.

Rhea-AI Filing Summary

PRVA reported Form 144 sales by an affiliated holder. The filing lists multiple issuer-reported restricted stock vesting entries (3/5/2026: 5,966 shares; 3/8/2026: 6,857 shares; 3/11/2026: 1,300 shares; 4/1/2026: 6,643 shares; 5/9/2026: 3,968 shares) and disclosed brokered sales by David Mountcastle totaling specific transactions on 4/2/2026, 5/1/2026, 5/4/2026, 5/11/2026, and 6/26/2026 with listed share counts and sale proceeds.

Insights

Corporate Governance Analyst

Form 144 lists routine dispositions tied to vested restricted stock and brokered sales.

The filing shows issuer-identified restricted stock vesting events totaling identifiable share units on specific dates in March–May 2026. Those vesting entries record compensation-related issuances to the holder.

Broker-reported sales by David Mountcastle are itemized with dates, share counts, and gross proceeds; timing and cash-flow counterparties are the broker and purchaser counterparties implied by the sale records.

Key Figures

Restricted shares vesting (03/05/2026): 5,966 shares Restricted shares vesting (03/08/2026): 6,857 shares Restricted shares vesting (03/11/2026): 1,300 shares +5 more

8 metrics

Restricted shares vesting (03/05/2026) 5,966 shares Restricted Stock Vesting

Restricted shares vesting (03/08/2026) 6,857 shares Restricted Stock Vesting

Restricted shares vesting (03/11/2026) 1,300 shares Restricted Stock Vesting

Restricted shares vesting (04/01/2026) 6,643 shares Restricted Stock Vesting

Restricted shares vesting (05/09/2026) 3,968 shares Restricted Stock Vesting

Sale on 06/26/2026 17,196 shares Brokered sale by David Mountcastle

Gross proceeds (06/26/2026 sale) $433,036.65 Proceeds reported for 17,196-share sale

Sale on 04/02/2026 5,566 shares Brokered sale by David Mountcastle

Key Terms

Form 144, Restricted Stock Vesting, Compensation, Brokered sale / proceeds

4 terms

Form 144 regulatory

"Filer Information | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted Stock Vesting financial

"03/05/2026 | Restricted Stock Vesting | Issuer"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

Compensation financial

"03/05/2026 | ... | Compensation"

Brokered sale / proceeds market

"David Mountcastle ... | Common | 06/26/2026 | 17196 | 433036.65"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did PRVA's Form 144 disclose about recent restricted stock vesting?

The filing lists restricted stock vesting on specific dates: 5,966, 6,857, 1,300, 6,643, and 3,968 shares on dates in March–May 2026. These entries are labeled as Compensation vesting events in the excerpt.

Who sold shares as reported on PRVA's Form 144?

The excerpt shows multiple brokered sales by David Mountcastle with transaction dates of 4/2/2026, 5/1/2026, 5/4/2026, 5/11/2026, and 6/26/2026 and corresponding share counts and proceeds listed in the filing.

What were the share counts and proceeds for the sales reported by David Mountcastle?

The filing lists these sales: 4/2/2026 — 5,566 shares, $116,055.55; 5/1/2026 — 7,179 shares, $179,680.74; 5/4/2026 — 1,206 shares, $30,150.00; 5/11/2026 — 3,385 shares, $76,512.85; 6/26/2026 — 17,196 shares, $433,036.65.

Does the Form 144 excerpt state who receives the sale proceeds?

The excerpt itemizes gross sale proceeds for each transaction but does not attach a party-receives statement; the reported proceeds are shown alongside each sale line in the brokered sale records in the excerpt.

Are the vesting entries described as compensation in the filing?

Yes; each restricted stock vesting line in the excerpt is labeled with the action and the purpose: the entry lists the date, the number of shares vesting, and the word Compensation adjacent to those vesting records.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/02/2026 - 04:17 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001858396
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Privia Health Group, Inc.
SEC File Number	001-40365
Address of Issuer	950 N. GLEBE RD., SUITE 700 ARLINGTON VIRGINIA 22203
Phone	571-366-8850
Name of Person for Whose Account the Securities are To Be Sold	Mountcastle David
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	24734	680187.50	126012374	07/02/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/05/2026	Restricted Stock Vesting	Issuer			5966	03/05/2026	Compensation
Common	03/08/2026	Restricted Stock Vesting	Issuer			6857	03/08/2026	Compensation
Common	03/11/2026	Restricted Stock Vesting	Issuer			1300	03/11/2026	Compensation
Common	04/01/2026	Restricted Stock Vesting	Issuer			6643	04/01/2026	Compensation
Common	05/09/2026	Restricted Stock Vesting	Issuer			3968	05/09/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
David Mountcastle 950 N. Glebe Rd Suite 700 Arlington VA 22203	Common	04/02/2026	5566	116055.55
David Mountcastle 950 N. Glebe Rd. Suite 700 Arlington VA 22203	Common	05/01/2026	7179	179680.74
David Mountcastle 950 N. Glebe Rd Suite 700 Arlington VA 22203	Common	05/04/2026	1206	30150.00
David Mountcastle 950 N. Glebe Rd. Suite 700 Arlington VA 22203	Common	05/11/2026	3385	76512.85
David Mountcastle 950 N. Glebe Rd. Suite 700 Arlington VA 22203	Common	06/26/2026	17196	433036.65

144: Remarks and Signature

Remarks
Date of Notice	07/02/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/13/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Joshua Schmitt, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for David Mountcastle.
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)